101D

REFINEMENT OF NETROPSIN BOUND TO DNA: BIAS AND FEEDBACK IN ELECTRON DENSITY MAP INTERPRETATION

101D の概要

• エントリーDOI: 10.2210/pdb101d/pdb
• 分子名称: DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(CBR)P*GP*CP*G)-3'), MAGNESIUM ION, NETROPSIN, ... (4 entities in total)
• 機能のキーワード: b-dna, double helix, complexed with drug, modified, dna
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 7939.35

構造登録者

Goodsell, D.S.,Kopka, M.L.,Dickerson, R.E. (登録日: 1994-12-14, 公開日: 1995-02-27, 最終更新日: 2023-11-22)

主引用文献

Goodsell, D.S.,Kopka, M.L.,Dickerson, R.E.
Refinement of netropsin bound to DNA: bias and feedback in electron density map interpretation.
Biochemistry, 34:4983-4993, 1995

PubMed Abstract: The X-ray crystal structure of the complex of the B-DNA dodecamer CGCGAATTCGCG with the antitumor drug netropsin has been reexamined to locate the drug accurately for computer-based drug design. The optimum solution is with the drug centered in the AATT region of the minor groove, making three good bifurcated hydrogen bonds with adenine N3 and thymine O2 atoms along the floor of the groove. Pyrrole rings of netropsin are packed against the C2 positions of adenines, leaving no room for the amine group of guanine and, hence, providing a structural rationale for the A.T specificity of netropsin. An alternative positioning in which the drug is shifted along the minor groove by ca. one-half base pair step is rejected on the basis of free R factor calculations and the appearance of the original drug-free difference maps. Final omit maps, although of more pleasing appearance, are not a dependable means of discriminating between right and wrong structures. The shifted alternative drug position ignores potential hydrogen bonding along the floor of the groove, provides no explanation for netropsin's observed A.T specificity, and is contradicted by NMR results [Patel, D. J. (1982) Proc. Natl. Acad. Sci. U.S.A. 79, 6424].

PubMed: 7711020
DOI: 10.1021/bi00015a009

実験手法

X-RAY DIFFRACTION (2.25 Å)